Cornerstone Pharmaceuticals

Cornerstone Pharmaceuticals

Cornerstone is committed to developing therapies for rare cancers. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD38—57m (Dealroom.co estimates Jan 2010.)
Cranbury Township New Jersey (HQ)
Authorizing premium user...